FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308785449> ?p ?o ?g. }

• W4308785449 abstract "Abstract STUDY QUESTION Can rapamycin improve the developmental competence of human oocytes during the IVM process? SUMMARY ANSWER Rapamycin at 10 nM could markedly improve the developmental competence of human oocytes undergoing IVM. WHAT IS KNOWN ALREADY Embryos derived from oocytes that mature in vitro have lower developmental competence than sibling embryos derived from oocytes matured in vivo. Rapamycin was shown to effectively improve IVM outcomes in mammalian oocytes; however, its effects on IVM of human oocytes have not been investigated. STUDY DESIGN, SIZE, DURATION In 2021, donated immature oocytes (n = 202) from 80 infertile couples receiving ICSI were included in a control group, and 156 oocytes from 72 couples were included in a rapamycin group. The oocytes underwent IVM with 10 nM rapamycin or without (control) rapamycin, followed by insemination by ICSI and embryo culture. PARTICIPANTS/MATERIALS, SETTING, METHODS The germinal vesicle breakdown (GVBD), maturation, normal fertilization, high-quality embryo (HQE) and blastocyst formation rates were calculated to evaluate the developmental competence of IVM oocytes, and fluorescence staining was used to assess DNA damage levels of oocytes in both groups. Whole-genome amplification and DNA sequencing were performed to analyze chromosome euploidy in embryos derived from the rapamycin group. MAIN RESULTS AND THE ROLE OF CHANCE The baseline characteristics of patients who donated oocytes for the two experimental groups were similar. In the control group, GVBD happened in 135 (66.8%) oocytes, and the maturation rate reached 52.5% at 24 h and 63.4% at 48 h. In the rapamycin group, 143 (91.7%) oocytes underwent GVBD, and the maturation rate reached 60.3% at 24 h and 82.7% at 48 h. Following ICSI, more HQEs were obtained in the rapamycin group versus control (34.2% versus 22.1%, respectively, P = 0.040), although with comparable fertilization rates in the two groups. In addition, the levels of histone γH2AX in oocytes cultured with 10 nM rapamycin were markedly decreased, compared with those in the control group (0.3 ± 0.0 versus 0.6 ± 0.1, respectively, P = 0.048). Embryos with normal karyotype could be obtained from oocytes cultured with rapamycin. LIMITATIONS, REASONS FOR CAUTION Our preliminary results indicated that the addition of rapamycin during human oocyte IVM did not cause extra aneuploidy. However, this safety evaluation of rapamycin treatment was based on limited samples and more data are needed before possible application in the clinic. WIDER IMPLICATIONS OF THE FINDINGS In the current study, 10 nM rapamycin was applied in the IVM process of human oocytes for the first time and showed positive effects, providing new insights for potentially improving IVM outcomes in the clinic. There were subtle differences between the results presented here on human oocytes and our previous studies on mouse oocytes, indicating the necessity of more research on human samples. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by the research grants from National Key Research and Development Project (2018YFC1002103) and Health Commission of Hubei Province scientific research project (WJ2021M110). All authors declared no conflicts of interest. TRIAL REGISTRATION NUMBER N/A." @default.
• W4308785449 created "2022-11-15" @default.
• W4308785449 creator A5003826922 @default.
• W4308785449 creator A5019047946 @default.
• W4308785449 creator A5021588861 @default.
• W4308785449 creator A5035282947 @default.
• W4308785449 creator A5036726873 @default.
• W4308785449 creator A5057803101 @default.
• W4308785449 creator A5064548792 @default.
• W4308785449 creator A5071738756 @default.
• W4308785449 date "2022-01-01" @default.
• W4308785449 modified "2023-10-18" @default.
• W4308785449 title "Rapamycin improves the developmental competence of human oocytes by alleviating DNA damage during IVM" @default.
• W4308785449 cites W1057736796 @default.
• W4308785449 cites W163818535 @default.
• W4308785449 cites W18843369 @default.
• W4308785449 cites W1885756489 @default.
• W4308785449 cites W1890579599 @default.
• W4308785449 cites W1988389022 @default.
• W4308785449 cites W2009725995 @default.
• W4308785449 cites W2043943754 @default.
• W4308785449 cites W2044387885 @default.
• W4308785449 cites W2046347248 @default.
• W4308785449 cites W2054167608 @default.
• W4308785449 cites W2071244315 @default.
• W4308785449 cites W2078840628 @default.
• W4308785449 cites W2097142668 @default.
• W4308785449 cites W2099401266 @default.
• W4308785449 cites W2102752109 @default.
• W4308785449 cites W2103362547 @default.
• W4308785449 cites W2110817748 @default.
• W4308785449 cites W2160456188 @default.
• W4308785449 cites W2162811744 @default.
• W4308785449 cites W2168500439 @default.
• W4308785449 cites W2198464760 @default.
• W4308785449 cites W2522831826 @default.
• W4308785449 cites W2550000794 @default.
• W4308785449 cites W2626632314 @default.
• W4308785449 cites W2790446406 @default.
• W4308785449 cites W2808738863 @default.
• W4308785449 cites W2809388751 @default.
• W4308785449 cites W2892249479 @default.
• W4308785449 cites W2896727034 @default.
• W4308785449 cites W2900783639 @default.
• W4308785449 cites W2986080105 @default.
• W4308785449 cites W2998460775 @default.
• W4308785449 cites W3020166545 @default.
• W4308785449 cites W3120702497 @default.
• W4308785449 cites W3182380636 @default.
• W4308785449 cites W3203903598 @default.
• W4308785449 cites W4200549965 @default.
• W4308785449 cites W4223981247 @default.
• W4308785449 cites W4253349890 @default.
• W4308785449 doi "https://doi.org/10.1093/hropen/hoac050" @default.
• W4308785449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36518986" @default.
• W4308785449 hasPublicationYear "2022" @default.
• W4308785449 type Work @default.
• W4308785449 citedByCount "3" @default.
• W4308785449 countsByYear W43087854492022 @default.
• W4308785449 countsByYear W43087854492023 @default.
• W4308785449 crossrefType "journal-article" @default.
• W4308785449 hasAuthorship W4308785449A5003826922 @default.
• W4308785449 hasAuthorship W4308785449A5019047946 @default.
• W4308785449 hasAuthorship W4308785449A5021588861 @default.
• W4308785449 hasAuthorship W4308785449A5035282947 @default.
• W4308785449 hasAuthorship W4308785449A5036726873 @default.
• W4308785449 hasAuthorship W4308785449A5057803101 @default.
• W4308785449 hasAuthorship W4308785449A5064548792 @default.
• W4308785449 hasAuthorship W4308785449A5071738756 @default.
• W4308785449 hasBestOaLocation W43087854492 @default.
• W4308785449 hasConcept C16685009 @default.
• W4308785449 hasConcept C196843134 @default.
• W4308785449 hasConcept C2775966511 @default.
• W4308785449 hasConcept C2776690073 @default.
• W4308785449 hasConcept C2777005246 @default.
• W4308785449 hasConcept C2778177303 @default.
• W4308785449 hasConcept C2781087480 @default.
• W4308785449 hasConcept C2994119143 @default.
• W4308785449 hasConcept C54355233 @default.
• W4308785449 hasConcept C71924100 @default.
• W4308785449 hasConcept C86803240 @default.
• W4308785449 hasConcept C87073359 @default.
• W4308785449 hasConcept C88972607 @default.
• W4308785449 hasConceptScore W4308785449C16685009 @default.
• W4308785449 hasConceptScore W4308785449C196843134 @default.
• W4308785449 hasConceptScore W4308785449C2775966511 @default.
• W4308785449 hasConceptScore W4308785449C2776690073 @default.
• W4308785449 hasConceptScore W4308785449C2777005246 @default.
• W4308785449 hasConceptScore W4308785449C2778177303 @default.
• W4308785449 hasConceptScore W4308785449C2781087480 @default.
• W4308785449 hasConceptScore W4308785449C2994119143 @default.
• W4308785449 hasConceptScore W4308785449C54355233 @default.
• W4308785449 hasConceptScore W4308785449C71924100 @default.
• W4308785449 hasConceptScore W4308785449C86803240 @default.
• W4308785449 hasConceptScore W4308785449C87073359 @default.
• W4308785449 hasConceptScore W4308785449C88972607 @default.
• W4308785449 hasIssue "4" @default.
• W4308785449 hasLocation W43087854491 @default.
• W4308785449 hasLocation W43087854492 @default.
• W4308785449 hasLocation W43087854493 @default.

• next